-
Start Preamble
Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby give of the following meeting.
The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Human Genome Research Institute Special Emphasis Panel.
Date: March 21, 2002.
Time: 1:00 PM to 3:00 PM.
Agenda: To review and evaluate grant applications.
Place: National Human Genome Research Institute, National Institutes of Health, Building 31, Room B2B32, Bethesda, MD 20892, (Telephone Conference Call).
Contact Person: Rudy O. Pozzatti, PHD, Scientific Review Administrator, Office of Scientific Review, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD 20892, 301 402-0838.
This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle.
Start Signature(Catalogue of Federal Domestic Assistance Program Nos. 93.172, Human Genome Research, National Institutes of Health, HHS)
Dated: March 21, 2002.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 02-7399 Filed 3-27-02; 8:45 am]
BILLING CODE 4140-01-M
Document Information
- Effective Date:
- 3/21/2002
- Published:
- 03/28/2002
- Department:
- National Institutes of Health
- Entry Type:
- Notice
- Document Number:
- 02-7399
- Dates:
- March 21, 2002.
- Pages:
- 14955-14955 (1 pages)
- PDF File:
- 02-7399.pdf